From: Psoriatic arthritis is associated with bone loss of the metacarpals
Total study group | |
---|---|
Total, n | 104 |
Women | 57 |
Men | 47 |
Age (years), mean ± SD | 54.7 ± 12.3 |
Height (cm), mean ± SD | 168 ± 9.0 |
Weight (kg), mean ± SD | 79 ± 16.7 |
Body mass index, mean ± SD | 27.6 ± 5.2 |
Disease duration (years), mean ± SD | 9.6 ± 6.7 |
Tender joint count (0–28 joints), mean ± SD | 2.5 ± 2.5 |
Swollen joint count (0–28 joints), mean ± SD | 2.3 ± 2.5 |
C-reactive protein (mg/l), mean ± SD | 9.8 ± 14.2 |
Erythrocyte sedimentation rate (mm/hour), mean ± SD | 16.3 ± 17.1 |
Corticosteroids, n (%) | |
Yes (mean dose 5 mg/day) | 28 (26.9) |
No | 76 (73.1) |
Non-steroidal anti-inflammatory drug, n (%) | 49 (47.1) |
Synthetic disease-modifying antirheumatic drugs, n (%) | 42 (40.4) |
Biological disease-modifying antirheumatic drugs, n (%) | 13 (12.5) |